SCHEMBL6407264

SCHEMBL6407264

c1ccc2c(N3CCN(c4c[nH]c5ccccc45)CC3)c[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
HTT P42858 3/20 0.51
GAA P10253 1/20 0.51
BCHE P06276 1/20 0.50
CYP2D6 P10635 1/20 0.50
HTR1A P08908 2/20 0.49
DRD2 P14416 5/20 0.49
DRD4 P21917 4/20 0.49
DRD3 P35462 4/20 0.49
HTR6 P50406 2/20 0.47
ADRB1 P08588 1/20 0.47
ATM Q13315 1/20 0.47
GFER P55789 1/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 2/20 0.45
TSHR P16473 1/20 0.45
MEN1 O00255 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2782013 0.92 LMNA (0.51) LMNAHTTGAABCHECYP2D6
SCHEMBL1413397 0.91 HTR6 (0.56) LMNAHTTGAAHTR1ADRD2
SCHEMBL1413377 0.90 HTT (0.54) LMNAHTTGAABCHECYP2D6
SCHEMBL1442314 0.89 HTR6 (0.63) LMNACYP2D6HTR1AHTR6ADRB1
Hydrochloric Acid SCHEMBL11852231 0.89 JAK2 (0.55) LMNAHTTGAABCHECYP2D6
SCHEMBL1413396 0.87 ALDH1A1 (0.55) LMNACYP2D6DRD2KDM4EALDH1A1
SCHEMBL7548171 0.87 BCHE (0.44) LMNAHTTGAABCHECYP2D6
SCHEMBL21047718 0.86 BCHE (0.42) LMNAHTTGAABCHECYP2D6
SCHEMBL18324896 0.85 LMNA (0.45) LMNAHTTGAABCHECYP2D6
SCHEMBL26912673 0.85 MAPT (0.59) LMNAHTTCYP2D6DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6841685-B2 Methods for making bis-heterocyclic alkaloids STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) 2005-01-11 US disclosed
US-20030232988-A1 Methods for making bis-heterocyclic alkaloids STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY,THE 2003-12-18 US disclosed
WO-2001094310-A1 METHODS FOR MAKING BIS-HETEROCYCLIC ALKALOIDS THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232988-A1 Methods for making bis-heterocyclic alkaloids CIAPIN1, AAAS, MDN1 LMNA 1516/4885HTT 175/4885GAA 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.